P50458
Gene name |
LHX2 (LH2) |
Protein name |
LIM/homeobox protein Lhx2 |
Names |
Homeobox protein LH-2, LIM homeobox protein 2 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:9355 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for P50458
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P50458-F1 | Predicted | AlphaFoldDB |
267 variants for P50458
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
CA374860669 rs1179688706 |
7 | S>L | No |
ClinGen gnomAD |
|
CA374860715 rs1425252450 |
13 | G>E | No |
ClinGen gnomAD |
|
rs968124826 CA199653136 |
16 | D>Y | No |
ClinGen Ensembl |
|
rs755380207 CA5233756 |
17 | E>K | No |
ClinGen ExAC gnomAD |
|
rs1262723657 CA374860752 |
18 | M>I | No |
ClinGen TOPMed |
|
CA5233757 rs767900210 |
18 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
CA374860756 rs1447163494 |
19 | D>G | No |
ClinGen gnomAD |
|
rs752934468 CA5233758 |
19 | D>N | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 20 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374860763 rs1324987801 |
20 | R>H | No |
ClinGen gnomAD |
|
CA374860765 rs1324987801 |
20 | R>L | No |
ClinGen gnomAD |
|
CA374860766 rs1407632691 |
21 | R>G | No |
ClinGen gnomAD |
|
CA5233759 rs756249258 |
22 | A>T | No |
ClinGen ExAC gnomAD |
|
CA374860803 rs777932165 |
26 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5233760 rs777932165 |
26 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1042853209 CA199653149 |
26 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA374860807 rs1218118920 |
27 | P>A | No |
ClinGen gnomAD |
|
rs1211321482 CA374860819 |
29 | I>V | No |
ClinGen TOPMed |
|
CA374860838 rs1486620338 |
31 | S>F | No |
ClinGen TOPMed |
|
rs1256675627 CA374860839 |
32 | A>S | No |
ClinGen TOPMed gnomAD |
|
CA374860853 rs1320625646 |
34 | D>H | No |
ClinGen gnomAD |
|
CA374860860 rs1267088691 |
35 | R>S | No |
ClinGen gnomAD |
|
CA374860866 rs1200510281 |
36 | G>S | No |
ClinGen TOPMed gnomAD |
|
CA374860874 rs1588343930 |
37 | D>A | No |
ClinGen Ensembl |
|
rs368708873 CA374860872 |
37 | D>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs368708873 CA5233761 |
37 | D>Y | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5233762 rs757223404 |
38 | T>A | No |
ClinGen ExAC gnomAD |
|
CA374860884 rs1360827094 |
39 | E>K | No |
ClinGen TOPMed |
|
rs1298032374 CA374860896 |
40 | T>M | No |
ClinGen TOPMed |
|
rs758295305 CA5233782 |
41 | T>A | No |
ClinGen ExAC gnomAD |
|
rs752440722 CA5233784 |
42 | M>L | No |
ClinGen ExAC gnomAD |
|
rs752440722 CA5233783 |
42 | M>V | No |
ClinGen ExAC gnomAD |
|
rs532587351 CA199653789 |
43 | P>L | No |
ClinGen ExAC gnomAD |
|
rs532587351 CA5233785 |
43 | P>R | No |
ClinGen ExAC gnomAD |
|
CA374860933 rs780690752 |
45 | I>F | No |
ClinGen ExAC TOPMed gnomAD |
|
rs780690752 CA5233786 |
45 | I>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs780690752 CA374860932 |
45 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA374860941 rs1287779088 |
46 | S>N | No |
ClinGen gnomAD |
|
CA374860943 rs1287779088 |
46 | S>T | No |
ClinGen gnomAD |
|
rs533198310 CA374860963 |
49 | R>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA5233789 rs533198310 |
49 | R>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
TCGA novel | 49 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374860965 rs1564548216 |
49 | R>P | No |
ClinGen Ensembl |
|
rs533198310 CA5233788 |
49 | R>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs113895098 CA199653804 |
50 | A>T | No |
ClinGen TOPMed gnomAD |
|
rs1188230279 CA374860972 |
51 | A>T | No |
ClinGen gnomAD |
|
CA374860993 rs1422020678 |
54 | A>S | No |
ClinGen TOPMed |
|
CA374860999 rs1362713822 |
55 | G>S | No |
ClinGen gnomAD |
|
CA374861012 rs1370844767 |
57 | G>R | No |
ClinGen gnomAD |
|
CA374861011 rs1370844767 |
57 | G>W | No |
ClinGen gnomAD |
|
TCGA novel | 58 | G>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1158464183 CA374861017 |
58 | G>S | No |
ClinGen TOPMed |
|
rs370570070 CA5233795 |
59 | K>R | No |
ClinGen ESP ExAC gnomAD |
|
rs1415274703 CA374861040 |
61 | S>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
rs1427452128 CA374861061 |
64 | Y>C | No |
ClinGen TOPMed |
|
TCGA novel | 69 | V>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374861099 rs1588344843 |
70 | D>G | No |
ClinGen Ensembl |
|
CA374861122 rs1376601922 |
73 | W>* | No |
ClinGen gnomAD |
|
rs867375573 CA199653837 |
76 | R>C | No |
ClinGen Ensembl |
|
rs1353984800 CA374861167 |
79 | K>R | No |
ClinGen gnomAD |
|
CA374861189 rs1231821859 |
82 | E>Q | No |
ClinGen gnomAD |
|
CA374861202 rs1253724724 |
83 | C>* | No |
ClinGen gnomAD |
|
CA374861285 rs1210127636 |
95 | S>T | No |
ClinGen TOPMed |
|
rs913850378 CA199653866 |
100 | I>S | No |
ClinGen TOPMed |
|
CA374861362 rs1419909165 |
104 | E>G | No |
ClinGen gnomAD |
|
rs1564548291 CA374861394 |
107 | Y>N | No |
ClinGen Ensembl |
|
rs901719061 CA199654296 |
109 | R>C | No |
ClinGen Ensembl |
|
rs1476903416 CA374861901 |
109 | R>L | No |
ClinGen gnomAD |
|
CA5233837 rs766398944 |
116 | A>G | No |
ClinGen ExAC gnomAD |
|
CA374861981 rs1469059585 |
117 | R>G | No |
ClinGen TOPMed |
|
CA374862176 rs1297242646 |
130 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
rs943713949 CA374862185 |
131 | A>P | No |
ClinGen TOPMed gnomAD |
|
CA199654321 rs943713949 |
131 | A>S | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 131 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA199654326 rs538436147 |
131 | A>V | No |
ClinGen Ensembl |
|
rs755961022 CA5233842 COSM3699265 |
132 | R>Q | large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
TCGA novel | 132 | R>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs763890377 CA5233843 |
134 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
rs753512234 CA5233844 |
139 | N>H | No |
ClinGen ExAC gnomAD |
|
rs756897654 CA5233845 |
139 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA199654348 rs549494441 |
142 | T>M | No |
ClinGen 1000Genomes gnomAD |
|
TCGA novel CA5233849 rs781712063 |
148 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
NCI-TCGA ClinGen ExAC TOPMed gnomAD |
rs1207316439 CA374862385 |
149 | M>L | No |
ClinGen TOPMed |
|
CA5233850 rs748558803 |
149 | M>T | No |
ClinGen ExAC gnomAD |
|
CA374862419 rs1588345478 |
151 | T>I | No |
ClinGen Ensembl |
|
CA374862504 rs1228926589 |
157 | G>C | No |
ClinGen TOPMed |
|
CA374862506 rs1180683785 |
157 | G>D | No |
ClinGen gnomAD |
|
rs1228926589 CA374862492 |
157 | G>S | No |
ClinGen TOPMed |
|
CA5233852 rs773524246 |
159 | K>E | No |
ClinGen ExAC gnomAD |
|
CA5233853 rs749532336 |
161 | S>N | No |
ClinGen ExAC gnomAD |
|
CA374862627 rs1420916571 |
166 | R>C | No |
ClinGen gnomAD |
|
rs1318426104 CA374862631 |
166 | R>H | No |
ClinGen gnomAD |
|
rs375687666 CA5233856 |
169 | F>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs368805518 CA5233858 |
174 | Q>L | No |
ClinGen ESP ExAC gnomAD |
|
rs1292248579 CA374862773 |
179 | A>S | No |
ClinGen gnomAD |
|
rs764015032 CA5233860 |
180 | H>Y | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs753641074 CA5233861 |
182 | N>K | No |
ClinGen ExAC gnomAD |
|
CA5233862 rs761390346 |
184 | A>D | No |
ClinGen ExAC TOPMed gnomAD |
|
rs757898602 CA5233866 |
185 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5233864 rs567713261 |
185 | D>N | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA5233867 rs753230621 |
186 | V>L | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 187 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA5233872 rs778123020 |
190 | A>S | No |
ClinGen ExAC gnomAD |
|
rs771124607 CA5233874 |
191 | A>S | No |
ClinGen ExAC gnomAD |
|
CA5233875 rs779183982 |
191 | A>V | No |
ClinGen ExAC gnomAD |
|
CA5233876 rs745984084 |
192 | A>E | No |
ClinGen ExAC TOPMed gnomAD |
|
CA374862932 rs1178079328 |
193 | A>V | No |
ClinGen TOPMed gnomAD |
|
rs775673483 CA5233879 |
194 | A>T | No |
ClinGen ExAC gnomAD |
|
rs1378909150 CA374862947 |
195 | A>T | No |
ClinGen TOPMed gnomAD |
|
rs961352521 CA199654443 |
195 | A>V | No |
ClinGen gnomAD |
|
rs1372315817 CA374862959 |
196 | A>T | No |
ClinGen TOPMed |
|
rs866465572 CA199654450 |
198 | S>R | No |
ClinGen Ensembl |
|
rs776576461 CA5233882 |
199 | A>S | No |
ClinGen ExAC gnomAD |
|
rs1162316630 CA374863015 |
201 | L>M | No |
ClinGen TOPMed |
|
CA5233886 rs762469815 |
202 | G>S | No |
ClinGen ExAC gnomAD |
|
rs765895014 CA5233887 |
203 | A>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs756617799 CA5233889 |
206 | A>S | No |
ClinGen ExAC gnomAD |
|
CA374863070 rs1465025643 |
207 | N>D | No |
ClinGen gnomAD |
|
rs754213670 CA5233891 |
208 | P>L | No |
ClinGen ExAC gnomAD |
|
rs1402161306 CA374863084 |
208 | P>S | No |
ClinGen gnomAD |
|
rs1200849534 CA374863105 |
210 | G>D | No |
ClinGen TOPMed |
|
CA5233893 rs779045579 |
210 | G>S | No |
ClinGen ExAC gnomAD |
|
rs1285259902 CA374863129 |
212 | P>L | No |
ClinGen TOPMed gnomAD |
|
CA374863137 rs1346306936 |
213 | Y>C | No |
ClinGen gnomAD |
|
rs1218534126 CA374863149 |
214 | Y>C | No |
ClinGen gnomAD |
|
rs1256772758 CA374863156 |
215 | N>H | No |
ClinGen gnomAD |
|
CA374863163 rs1341845501 |
215 | N>S | No |
ClinGen gnomAD |
|
CA5233895 rs189601606 |
217 | V>M | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1158234741 CA374863198 |
218 | G>D | No |
ClinGen gnomAD |
|
rs1221785548 CA374863211 |
220 | V>M | No |
ClinGen TOPMed |
|
CA374863275 rs1268970668 |
225 | P>L | No |
ClinGen gnomAD |
|
rs1054695991 CA199654503 |
226 | R>K | No |
ClinGen Ensembl |
|
rs1191389072 CA374863291 |
227 | K>R | No |
ClinGen gnomAD |
|
CA374863300 rs1374754197 |
228 | R>C | No |
ClinGen gnomAD |
|
rs1475581575 CA374863303 |
228 | R>P | No |
ClinGen gnomAD |
|
CA374863297 rs1374754197 |
228 | R>S | No |
ClinGen gnomAD |
|
rs747022702 CA5233897 |
229 | K>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs768784762 CA5233898 |
230 | S>I | No |
ClinGen ExAC gnomAD |
|
rs776604677 CA5233899 |
231 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA199654518 rs571577241 |
231 | P>S | No |
ClinGen 1000Genomes |
|
TCGA novel | 232 | G>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374863350 rs1366254572 |
233 | P>A | No |
ClinGen gnomAD |
|
rs754466751 CA199654526 |
234 | G>C | No |
ClinGen TOPMed gnomAD |
|
CA374863369 rs1328709712 |
235 | A>V | No |
ClinGen gnomAD |
|
rs772832117 CA5233902 |
236 | D>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
rs901604624 CA199654534 |
238 | A>S | No |
ClinGen gnomAD |
|
rs901604624 CA374863391 |
238 | A>T | No |
ClinGen gnomAD |
|
rs995859788 CA199654538 |
238 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA374863407 rs1177515868 |
239 | A>G | No |
ClinGen TOPMed |
|
CA374863403 rs1363594530 |
239 | A>S | No |
ClinGen TOPMed |
|
rs1481720994 CA374863418 |
240 | Y>C | No |
ClinGen TOPMed |
|
rs1050701333 CA199654541 |
241 | N>K | No |
ClinGen TOPMed |
|
CA374863431 rs1292114193 |
241 | N>S | No |
ClinGen TOPMed gnomAD |
|
rs762679057 CA5233903 |
242 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs887606540 CA199654548 |
242 | A>V | No |
ClinGen Ensembl |
|
rs560527359 CA5233930 |
243 | A>G | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA374864347 rs560527359 |
243 | A>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1588348683 CA374864363 |
245 | S>R | No |
ClinGen Ensembl |
|
rs751859167 CA5233933 |
246 | C>S | No |
ClinGen ExAC gnomAD |
|
CA374864372 rs1316266589 |
247 | N>H | No |
ClinGen Ensembl |
|
CA374864379 rs755198475 |
247 | N>K | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 248 | E>missing | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs879062209 CA199657918 |
248 | E>G | No |
ClinGen Ensembl |
|
rs1303464139 CA374864380 |
248 | E>K | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA374864393 rs1456308379 CA374864394 |
249 | N>K | No |
ClinGen gnomAD |
|
TCGA novel | 250 | D>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374864395 rs1306991006 |
250 | D>N | No |
ClinGen TOPMed |
|
CA199657923 rs973270362 |
251 | A>S | No |
ClinGen TOPMed gnomAD |
|
CA374864405 rs973270362 |
251 | A>T | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 252 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs781342669 CA5233935 |
252 | E>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
rs748107648 CA5233936 |
253 | H>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1471239345 CA374864440 |
254 | L>V | No |
ClinGen gnomAD |
|
rs1177834475 CA374864450 |
255 | D>N | No |
ClinGen gnomAD |
|
rs777556738 CA5233938 |
256 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
rs777556738 CA199657937 |
256 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
rs749130254 CA199657952 COSM1459940 |
256 | R>H | large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
rs749130254 CA5233939 |
256 | R>P | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5233941 rs770682530 |
257 | D>A | No |
ClinGen ExAC gnomAD |
|
rs979762975 CA199657970 |
258 | Q>K | No |
ClinGen Ensembl |
|
CA5233942 rs140229756 |
259 | P>Q | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs771568317 CA5233944 |
261 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs771568317 CA374864522 |
261 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs760101514 CA5233946 |
266 | T>I | No |
ClinGen ExAC gnomAD |
|
CA5233949 rs763510121 |
269 | M>I | No |
ClinGen ExAC gnomAD |
|
CA5233951 rs751912499 |
286 | A>T | No |
ClinGen ExAC gnomAD |
|
rs1274615285 CA374865310 |
288 | N>D | No |
ClinGen gnomAD |
|
CA199658014 rs767627020 |
292 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
TCGA novel | 297 | K>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374865444 rs1355543482 |
298 | Q>H | No |
ClinGen gnomAD |
|
CA5233954 rs752878477 |
300 | A>P | No |
ClinGen ExAC TOPMed gnomAD |
|
TCGA novel | 301 | Q>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374865509 rs1405055112 |
304 | G>D | No |
ClinGen gnomAD |
|
rs779800895 CA5233981 |
317 | A>T | No |
ClinGen ExAC gnomAD |
|
rs747654439 CA5233985 |
321 | F>L | No |
ClinGen ExAC gnomAD |
|
rs1449784215 CA374866161 |
323 | R>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
CA374866164 rs1338436392 |
323 | R>L | No |
ClinGen gnomAD |
|
CA374866188 rs1453619025 |
327 | R>Q | No |
ClinGen gnomAD |
|
CA5233986 rs771622276 |
329 | E>G | No |
ClinGen ExAC gnomAD |
|
rs774975929 CA5233987 |
330 | N>K | No |
ClinGen ExAC gnomAD |
|
rs1371216473 CA374866209 |
330 | N>T | No |
ClinGen gnomAD |
|
CA5233989 rs772345058 |
332 | G>A | No |
ClinGen ExAC gnomAD |
|
rs1462081942 CA374866226 |
333 | V>E | No |
ClinGen gnomAD |
|
rs151109428 CA5233990 |
333 | V>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA374866236 rs1564553864 |
334 | D>E | No |
ClinGen Ensembl |
|
rs764241410 CA5233992 |
336 | S>L | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 336 | S>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs762693228 CA374866267 |
339 | A>E | No |
ClinGen ExAC gnomAD |
|
rs1177285065 CA374866264 |
339 | A>T | No |
ClinGen gnomAD |
|
rs762693228 CA5233994 |
339 | A>V | No |
ClinGen ExAC gnomAD |
|
CA374866269 rs1195957735 COSM752738 |
340 | A>T | lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
rs1178554096 CA374866274 |
340 | A>V | No |
ClinGen TOPMed gnomAD |
|
CA374866282 rs1564553894 |
342 | Q>* | No |
ClinGen Ensembl |
|
rs1328391312 CA374866286 |
342 | Q>H | No |
ClinGen gnomAD |
|
rs1325983747 CA374866298 |
344 | G>E | No |
ClinGen TOPMed |
|
rs1444394983 CA374866303 |
345 | T>M | No |
ClinGen gnomAD |
|
rs751314499 CA5233999 |
346 | P>S | No |
ClinGen ExAC gnomAD |
|
CA5234000 rs751314499 |
346 | P>T | No |
ClinGen ExAC gnomAD |
|
CA199663328 rs369099431 |
347 | S>L | No |
ClinGen ESP TOPMed gnomAD |
|
rs780990221 COSM752737 CA5234001 |
348 | G>V | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
CA374866321 rs1166683585 |
349 | P>A | No |
ClinGen TOPMed |
|
rs1324665644 CA374866323 |
349 | P>L | No |
ClinGen TOPMed gnomAD |
|
rs1324665644 CA374866325 |
349 | P>R | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 350 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374866345 rs1267522986 |
352 | E>D | No |
ClinGen gnomAD |
|
rs777369931 CA5234006 |
353 | L>F | No |
ClinGen ExAC gnomAD |
|
CA5234007 rs746392772 |
355 | N>D | No |
ClinGen ExAC gnomAD |
|
CA374866363 rs1429949286 |
355 | N>K | No |
ClinGen TOPMed gnomAD |
|
rs893877314 CA199663365 |
355 | N>S | No |
ClinGen Ensembl |
|
CA5234008 rs772563433 |
356 | A>T | No |
ClinGen ExAC gnomAD |
|
CA5234009 COSM384154 rs775730128 |
357 | S>L | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
CA374866400 rs1203399461 |
359 | S>R | No |
ClinGen TOPMed |
|
CA374866492 rs1329850991 |
365 | T>A | No |
ClinGen gnomAD |
|
CA5234012 rs776799769 |
365 | T>I | No |
ClinGen ExAC gnomAD |
|
CA374866507 rs1403212401 |
366 | T>I | No |
ClinGen gnomAD |
|
CA374866518 rs1305418533 |
367 | L>R | No |
ClinGen gnomAD |
|
rs761926920 CA5234013 |
368 | T>K | No |
ClinGen ExAC gnomAD |
|
rs765319512 CA5234014 |
369 | D>G | No |
ClinGen ExAC gnomAD |
|
rs551135959 CA5234015 |
371 | T>A | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs762815287 CA5234016 |
371 | T>I | No |
ClinGen ExAC gnomAD |
|
rs762815287 CA374866568 |
371 | T>N | No |
ClinGen ExAC gnomAD |
|
CA374866564 rs551135959 |
371 | T>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1448778106 CA374866615 |
375 | L>V | No |
ClinGen gnomAD |
|
CA374866639 rs1489617052 |
377 | T>A | No |
ClinGen TOPMed gnomAD |
|
CA5234018 rs569272766 |
377 | T>I | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1489617052 CA374866635 |
377 | T>P | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 378 | V>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA5234020 rs533321722 |
379 | T>A | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA gnomAD |
CA5234021 rs752421293 |
379 | T>M | No |
ClinGen ExAC gnomAD |
|
rs533321722 CA5234019 |
379 | T>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA374866684 rs1475631589 |
381 | V>I | No |
ClinGen gnomAD |
|
rs1169421382 CA374866715 |
383 | T>S | No |
ClinGen gnomAD |
|
rs1352151504 CA374866733 |
385 | V>L | No |
ClinGen TOPMed |
|
CA374866758 rs1305979331 |
387 | G>D | No |
ClinGen TOPMed |
|
CA5234023 rs777152260 |
387 | G>R | No |
ClinGen ExAC gnomAD |
|
CA374866773 rs1165531483 |
388 | N>K | No |
ClinGen gnomAD |
|
CA374866785 rs1366341343 |
389 | L>R | No |
ClinGen gnomAD |
|
TCGA novel | 394 | P>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA374866848 rs1316908197 |
394 | P>T | No |
ClinGen gnomAD |
|
rs1455981403 CA374866890 |
397 | P>T | No |
ClinGen TOPMed |
|
rs1588354517 CA374866913 |
398 | S>L | No |
ClinGen Ensembl |
|
CA5234028 rs768983413 |
399 | Q>R | No |
ClinGen ExAC gnomAD |
|
rs781483915 CA5234029 |
400 | T>A | No |
ClinGen ExAC gnomAD |
|
CA199663472 rs998449551 |
400 | T>M | No |
ClinGen TOPMed |
|
rs1203260098 CA374866944 |
401 | T>A | No |
ClinGen gnomAD |
|
rs769950167 CA5234031 |
404 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
TCGA novel | 406 | F>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
No associated diseases with P50458
9 regional properties for P50458
Type | Name | Position | InterPro Accession |
---|---|---|---|
repeat | Leucine-rich repeat | 86 - 152 | IPR001611-1 |
repeat | Leucine-rich repeat | 153 - 211 | IPR001611-2 |
repeat | Leucine-rich repeat | 222 - 280 | IPR001611-3 |
repeat | Leucine-rich repeat, typical subtype | 105 - 127 | IPR003591-1 |
repeat | Leucine-rich repeat, typical subtype | 128 - 151 | IPR003591-2 |
repeat | Leucine-rich repeat, typical subtype | 175 - 197 | IPR003591-3 |
repeat | Leucine-rich repeat, typical subtype | 198 - 220 | IPR003591-4 |
repeat | Leucine-rich repeat, typical subtype | 221 - 243 | IPR003591-5 |
repeat | Leucine-rich repeat, typical subtype | 244 - 267 | IPR003591-6 |
2 GO annotations of cellular component
Name | Definition |
---|---|
chromatin | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
6 GO annotations of molecular function
Name | Definition |
---|---|
chromatin binding | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
DNA-binding transcription activator activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
metal ion binding | Binding to a metal ion. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
RNA polymerase II transcription regulatory region sequence-specific DNA binding | Binding to a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II. |
18 GO annotations of biological process
Name | Definition |
---|---|
axon extension | Long distance growth of a single axon process involved in cellular development. |
axon guidance | The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. |
cerebral cortex development | The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon. |
dorsal/ventral pattern formation | The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism. |
hair follicle development | The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. |
maintenance of epithelial cell apical/basal polarity | The maintenance of the apicobasal polarity of an epithelial cell. |
mesoderm development | The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue. |
negative regulation of gene expression, epigenetic | An epigenetic process that silences gene expression at specific genomic regions through chromatin remodelling either by modifying higher order chromatin fiber structure, nucleosomal histones, or the DNA. |
negative regulation of neurogenesis | Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system. |
negative regulation of transcription regulatory region DNA binding | Any process that stops, prevents or reduces the frequency, rate or extent of transcription regulatory region DNA binding. |
neural tube closure | The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. |
neuron differentiation | The process in which a relatively unspecialized cell acquires specialized features of a neuron. |
olfactory bulb development | The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex. |
positive regulation of DNA-templated transcription | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
positive regulation of neural precursor cell proliferation | Any process that activates or increases the frequency, rate or extent of neural precursor cell proliferation. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
retina development in camera-type eye | The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates. |
telencephalon regionalization | The regionalization process that creates areas within the forebrain that will direct the behavior of cell migration in differentiation as the telencephalon develops. |
21 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A0JNI8 | LHX9 | LIM/homeobox protein Lhx9 | Bos taurus (Bovine) | PR |
Q90881 | LHX9 | LIM/homeobox protein Lhx9 | Gallus gallus (Chicken) | PR |
F1NEA7 | DMBX1 | Diencephalon/mesencephalon homeobox protein 1 | Gallus gallus (Chicken) | PR |
Q90963 | PRRX2 | Paired mesoderm homeobox protein 2 | Gallus gallus (Chicken) | PR |
Q8IRC7 | Awh | LIM/homeobox protein Awh | Drosophila melanogaster (Fruit fly) | PR |
Q8NHV9 | RHOXF1 | Rhox homeobox family member 1 | Homo sapiens (Human) | PR |
O95076 | ALX3 | Homeobox protein aristaless-like 3 | Homo sapiens (Human) | PR |
Q9BQY4 | RHOXF2 | Rhox homeobox family member 2 | Homo sapiens (Human) | PR |
Q99811 | PRRX2 | Paired mesoderm homeobox protein 2 | Homo sapiens (Human) | PR |
O15266 | SHOX | Short stature homeobox protein | Homo sapiens (Human) | PR |
Q9NQ69 | LHX9 | LIM/homeobox protein Lhx9 | Homo sapiens (Human) | PR |
P63013 | Prrx1 | Paired mesoderm homeobox protein 1 | Mus musculus (Mouse) | PR |
Q8VIH1 | Nobox | Homeobox protein NOBOX | Mus musculus (Mouse) | PR |
Q06348 | Prrx2 | Paired mesoderm homeobox protein 2 | Mus musculus (Mouse) | PR |
O88933 | Esx1 | Extraembryonic, spermatogenesis, homeobox 1 (Homeobox protein SPX1) (Homeodomain protein EPX) | Mus musculus (Mouse) | EV |
Q9WUH2 | Lhx9 | LIM/homeobox protein Lhx9 | Mus musculus (Mouse) | PR |
Q80W90 | Lhx9 | LIM/homeobox protein Lhx9 | Rattus norvegicus (Rat) | PR |
P36198 | Lhx2 | LIM/homeobox protein Lhx2 | Rattus norvegicus (Rat) | PR |
Q28G02 | siamois | Homeobox protein siamois | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | PR |
Q566X8 | dmbx1b | Diencephalon/mesencephalon homeobox protein 1-B | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
Q1LWV4 | lhx9 | LIM/homeobox protein Lhx9 | Danio rerio (Zebrafish) (Brachydanio rerio) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MLFHSLSGPE | VHGVIDEMDR | RAKSEAPAIS | SAIDRGDTET | TMPSISSDRA | ALCAGCGGKI |
70 | 80 | 90 | 100 | 110 | 120 |
SDRYYLLAVD | KQWHMRCLKC | CECKLNLESE | LTCFSKDGSI | YCKEDYYRRF | SVQRCARCHL |
130 | 140 | 150 | 160 | 170 | 180 |
GISASEMVMR | ARDLVYHLNC | FTCTTCNKML | TTGDHFGMKD | SLVYCRLHFE | ALLQGEYPAH |
190 | 200 | 210 | 220 | 230 | 240 |
FNHADVAAAA | AAAAAAKSAG | LGAAGANPLG | LPYYNGVGTV | QKGRPRKRKS | PGPGADLAAY |
250 | 260 | 270 | 280 | 290 | 300 |
NAALSCNEND | AEHLDRDQPY | PSSQKTKRMR | TSFKHHQLRT | MKSYFAINHN | PDAKDLKQLA |
310 | 320 | 330 | 340 | 350 | 360 |
QKTGLTKRVL | QVWFQNARAK | FRRNLLRQEN | TGVDKSTDAA | LQTGTPSGPA | SELSNASLSP |
370 | 380 | 390 | 400 | ||
SSTPTTLTDL | TSPTLPTVTS | VLTSVPGNLE | GHEPHSPSQT | TLTNLF |